Cargando…
In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery. However, 10%–20% restenosis is still an important complication that restricts the clinical safety and eff...
Autores principales: | Zhang, Dai-Min, Chen, Shaoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605950/ https://www.ncbi.nlm.nih.gov/pubmed/33163230 http://dx.doi.org/10.1155/2020/8104939 |
Ejemplares similares
-
What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022) -
Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018) -
Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023) -
Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis
por: Elwany, Mostafa, et al.
Publicado: (2018) -
Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)